Salvaging hope: Is increasing NAD(+) a key to treating mitochondrial myopathy?

Mitochondrial diseases can arise from mutations either in mitochondrial DNA or in nuclear DNA encoding mitochondrially destined proteins. Currently, there is no cure for these diseases although treatments to ameliorate a subset of the symptoms are being developed. In this issue of EMBO Molecular Med...

Descripción completa

Detalles Bibliográficos
Autores principales: Lightowlers, Robert N, Chrzanowska-Lightowlers, Zofia MA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Closeup
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203349/
https://www.ncbi.nlm.nih.gov/pubmed/24838280
http://dx.doi.org/10.15252/emmm.201404179
Descripción
Sumario:Mitochondrial diseases can arise from mutations either in mitochondrial DNA or in nuclear DNA encoding mitochondrially destined proteins. Currently, there is no cure for these diseases although treatments to ameliorate a subset of the symptoms are being developed. In this issue of EMBO Molecular Medicine, Khan et al (2014) use a mouse model to test the efficacy of a simple dietary supplement of nicotinamide riboside to treat and prevent mitochondrial myopathies.

Ejemplares similares